3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
6
Leukemia, Myeloid, Acute
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia
4
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Hodgkin Disease
3
Anemia, Refractory, with Excess of Blasts
3
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Multiple Myeloma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Hematologic Neoplasms
2
Congenital Abnormalities
2
Blast Crisis
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Mantle-Cell
1
Interventions
Fulvestrant
26
Letrozole
25
Specimen Handling
19
ribociclib
18
Capecitabine
16
pembrolizumab
15
palbociclib
13
Trastuzumab
13
Paclitaxel
13
abemaciclib
12
Tamoxifen
12
Anastrozole
12
exemestane
11
Magnetic Resonance Spectroscopy
11
trastuzumab deruxtecan
10
Carboplatin
10
Biopsy
9
pertuzumab
8
Goserelin
8
inavolisib
6
Standard of Care
6
Cyclophosphamide
6
olaparib
5
giredestrant
5
elacestrant
5
Taxes
5
Radiotherapy
5
Radiation
5
130-nm albumin-bound paclitaxel
5
pyrotinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Busulfan
×
30 days
×
Clear all
No trials found.